Litvinov S, Kryukova I, Hint E, Purde M
Arch Geschwulstforsch. 1986;56(6):407-12.
The presence of antibodies to MuMTV-related proteins in sera of 31 mammary carcinoma patients' healthy daughters have been tested by indirect immunoperoxidase method (ELISA). Ten of them (32.3 +/- 8.4%) reacted with MuMTV proteins preparations, but not with MuLV, RaLV, SSV, MPMV proteins or preparations of mouse embryonic tissues. The percent of positive sera in this group is almost ten times higher than among women without breast cancer in family history (earlier published data). By immunoblotting method the specificity for five positive sera was determined. Two sera react with p27, one with p27 and to a less extent with gp52, one-only with gp52 and one more serum with both proteins equally. Mothers of the daughters with positive-reacted sera were characterized by premenopausal tumors, detected on early (I, IIa) clinical stage of disease.
采用间接免疫过氧化物酶法(ELISA)检测了31例乳腺癌患者健康女儿血清中抗MuMTV相关蛋白的抗体。其中10例(32.3±8.4%)与MuMTV蛋白制剂发生反应,但不与MuLV、RaLV、SSV、MPMV蛋白或小鼠胚胎组织制剂发生反应。该组阳性血清的百分比几乎是家族史中无乳腺癌女性(先前发表的数据)的10倍。通过免疫印迹法确定了5份阳性血清的特异性。两份血清与p27反应,一份与p27反应且在较小程度上与gp52反应,一份仅与gp52反应,另一份血清与两种蛋白反应程度相同。血清反应呈阳性的女儿的母亲的特征是绝经前肿瘤,在疾病的早期(I、IIa)临床阶段被检测到。